申请人:Taiyo Pharmaceutical Industry Co., Ltd.
公开号:US04762927A1
公开(公告)日:1988-08-09
The invention provides an indene compound represented by the following general formula (I): ##STR1## wherein R.sub.1 means a lower alkyl group, R.sub.2 and R.sub.3 denote a lower alkyl group individually or an alkylenedioxy group in combination, and R.sub.4 and R.sub.5 mean individually a substituted or unsubstituted lower alkyl or aryl group or in combination a substituted or unsubstituted piperidino, piperazinyl or homopiperazinyl group together with the adjacent nitrogen atom, with a proviso that not both R.sub.4 and R.sub.5 are a methyl group at the same time.
该发明提供了一种由以下一般式(I)表示的茚化合物:其中R.sub.1表示较低的烷基基团,R.sub.2和R.sub.3分别表示较低的烷基基团或与之组合的烷二氧基基团,R.sub.4和R.sub.5分别表示取代或未取代的较低烷基或芳基团,或者与相邻氮原子一起组合成取代或未取代的哌啶基、哌嗪基或同源哌嗪基,但R.sub.4和R.sub.5不能同时为甲基基团。